Radiochemical Investigations for Radiopharmaceutical Nuclear Medicine at JINR Laboratory of Nuclear Problems

[1]  P. Schaffer,et al.  An alternative radiochemical separation strategy for isolation of Ac and Ra isotopes from high energy proton irradiated thorium targets for further application in Targeted Alpha Therapy (TAT). , 2022, Nuclear medicine and biology.

[2]  C. Orvig,et al.  Improved separation scheme for 44Sc produced by irradiation of natCa targets with 12.8 MeV protons. , 2021, Nuclear medicine and biology.

[3]  T. Schneider,et al.  Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy , 2021, Frontiers in Medicine.

[4]  D. Filosofov,et al.  Radiochemical aspects in modern radiopharmaceutical trends: a practical guide , 2021, Solvent Extraction and Ion Exchange.

[5]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[6]  J. Kozempel,et al.  Sorption of various elements on ion-exchange resins in acetic media , 2021, Journal of Radioanalytical and Nuclear Chemistry.

[7]  Villas Bôas.  Stability in production and transport of 177 Lu labeled PSMA , 2021 .

[8]  U. Haberkorn,et al.  Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with 225Ac-PSMA-617 targeted alpha-radiation therapy. , 2020, Urologic oncology.

[9]  D. Filosofov,et al.  Potent candidates for Targeted Auger Therapy: Production and radiochemical considerations. , 2020, Nuclear medicine and biology.

[10]  H. Kung,et al.  Synthesis and Evaluation of 68Ga- and 177Lu-Labeled (R)- vs (S)-DOTAGA Prostate-Specific Membrane Antigen-Targeting Derivatives. , 2020, Molecular pharmaceutics.

[11]  C. Stief,et al.  First Clinical Results for PSMA-Targeted α-Therapy Using 225Ac-PSMA-I&T in Advanced-mCRPC Patients , 2020, The Journal of Nuclear Medicine.

[12]  G. Bonchev,et al.  Perturbed Angular Correlation as a Tool to Study Precursors for Radiopharmaceuticals. , 2020, Inorganic chemistry.

[13]  V. N. Fedosseev,et al.  CERN-MEDICIS: A UNIQUE FACILITY FOR THE PRODUCTION OF NONCONVENTIONAL RADIONUCLIDES FOR THE MEDICAL RESEARCH , 2020 .

[14]  Justin J. Wilson,et al.  MACROPA highly stable chelator of Radium-223 and functionalization attempts for targeted treatment of cancer , 2020 .

[15]  A. Jeremie.  The SuperNEMO demonstrator double beta experiment , 2020 .

[16]  V. Radchenko,et al.  Production of 111In and Radioisotopes of Te and Sn from an Antimony Target Irradiated with High-Energy Protons , 2020, Radiochemistry.

[17]  A. Ringvall-Moberg,et al.  Offline 2, ISOLDE’s target, laser and beams development facility , 2020 .

[18]  A. Kovalík,et al.  Various Applications of Precision Low-Energy Nuclear Electron Spectrometry in the KATRIN Tritium Neutrino Project , 2019, Physics of Particles and Nuclei.

[19]  D. Filosofov,et al.  Distribution Coefficients of 60 Elements on Cation and Anion-Exchange Resin in Ammonium Chloride Solutions , 2019, Solvent Extraction and Ion Exchange.

[20]  M. Milanova,et al.  Rare earths doped ferrites, characterized by Time Differential γγ Perturbed Angle Correlations method , 2019, Journal of Solid State Chemistry.

[21]  P. Martini,et al.  A Picture of Modern Tc-99m Radiopharmaceuticals: Production, Chemistry, and Applications in Molecular Imaging , 2019, Applied Sciences.

[22]  C. Cerna,et al.  Development of methods for the preparation of radiopure 82Se sources for the SuperNEMO neutrinoless double-beta decay experiment , 2019, Radiochimica Acta.

[23]  R. Schibli,et al.  Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[24]  M. Milanova,et al.  Sorption of Rare-earth Elements and Ac on DN resin with HCl, HClO4, CH3COOH, CCl3COOH , 2018, Solvent Extraction and Ion Exchange.

[25]  N. Lebedev,et al.  172Hf → 172Lu Radionuclide Generator Based on a Reverse-Tandem Separation Scheme , 2018, Radiochemistry.

[26]  P. Schaffer,et al.  Utilization of (p, 4n) reaction for 86Zr production with medium energy protons and development of a 86Zr → 86Y radionuclide generator , 2018, Journal of Radioanalytical and Nuclear Chemistry.

[27]  M. Hofman,et al.  Prostate-specific membrane antigen theranostics: therapy with lutetium-177 , 2017, Current opinion in urology.

[28]  B. Paul,et al.  Optimizing EDELWEISS detectors for low-mass WIMP searches , 2017, 1707.04308.

[29]  O. Kochetov,et al.  Use of 44Ti in the time-differential γγ perturbed-angular- correlation method for studying condensed matter , 2017 .

[30]  M. Milanova,et al.  Sorption of Rare-Earth Elements and Ac on UTEVA Resin in Different Acid Solutions , 2017 .

[31]  Chuanqin Xia,et al.  68Ga/177Lu-labeled DOTA-TATE shows similar imaging and biodistribution in neuroendocrine tumor model , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[32]  J. G. Correia,et al.  TDPAC and β-NMR applications in chemistry and biochemistry , 2017 .

[33]  M. Misiaszek,et al.  Background-free search for neutrinoless double-β decay of 76Ge with GERDA , 2017, Nature.

[34]  M. Milanova,et al.  Determination of distribution coefficients (Kd) of various radionuclides on UTEVA resin , 2016 .

[35]  F. Roesch,et al.  Direct flow separation strategy, to isolate no-carrier-added 90Nb from irradiated Mo or Zr targets , 2016 .

[36]  F. Mottaghy,et al.  225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer , 2016, The Journal of Nuclear Medicine.

[37]  A. Harris,et al.  Labeling and preliminary in vivo assessment of niobium-labeled radioactive species: A proof-of-concept study. , 2016, Nuclear medicine and biology.

[38]  V. K. Utyonkov,et al.  Superheavy nuclei from 48 Ca-induced reactions , 2015 .

[39]  Michael Lassmann,et al.  68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies , 2015, The Journal of Nuclear Medicine.

[40]  I. Velikyan.  68Ga-Based Radiopharmaceuticals: Production and Application Relationship , 2015, Molecules.

[41]  F. Roesch,et al.  Behavior of Actinium, Alkaline, and Rare Earth Elements in Sr-Resin/Mineral Acid Systems , 2015 .

[42]  Anders Sundin,et al.  Dose Response of Pancreatic Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy Using 177Lu-DOTATATE , 2015, The Journal of Nuclear Medicine.

[43]  M. Eisenhut,et al.  Separation of 90Nb from zirconium target for application in immuno-PET , 2014 .

[44]  O. Kochetov,et al.  Purification of selenium from thorium, uranium, radium, actinium and potassium impurities for low background measurements , 2013 .

[45]  M. Pillai,et al.  Targeted radionuclide therapy--an overview. , 2013, Current radiopharmaceuticals.

[46]  G. Bozhikov,et al.  Isolation of radionuclides from thorium targets irradiated with 300-MeV protons , 2013, Radiochemistry.

[47]  C. Orvig,et al.  Tumour targeting with radiometals for diagnosis and therapy. , 2013, Chemical communications.

[48]  R. Dreyer,et al.  Electromigration of Carrier-free Radionuclides 11 . Complex Formation of 239 Np ( V ) with Oxalate , Tartrate and Sulphate in Neutral Inert Electrolytes , 2013 .

[49]  Lynn C Francesconi,et al.  PET imaging with ⁸⁹Zr: from radiochemistry to the clinic. , 2013, Nuclear medicine and biology.

[50]  G. V. van Dongen,et al.  90Nb – a potential PET nuclide: production and labeling of monoclonal antibodies , 2012 .

[51]  F. Rösch,et al.  The Szilard–Chalmers effect in macrocyclic ligands to increase the specific activity of reactor-produced radiolanthanides: Experiments and explanations , 2012 .

[52]  T. Butz,et al.  Perturbed Angular Correlations of γ‐rays (PAC) Spectroscopy , 2011 .

[53]  F. Rösch,et al.  Post-elution processing of (44)Ti/(44)Sc generator-derived (44)Sc for clinical application. , 2010, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[54]  F. Rösch,et al.  Elektromigration von γ-Radionukliden in homogenen wäßrigen Elektrolyten ohne Zusatz stabilisierender Träger , 2010 .

[55]  N. Aksenov,et al.  Anion Exchange Behavior Of Ti, Zr, Hf, Nb And Ta As Homologues Of Rf And Db In Mixed HF--Acetone Solutions , 2010 .

[56]  B. Wessels,et al.  MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of α-Particle Emitters for Targeted Radionuclide Therapy* , 2010, Journal of Nuclear Medicine.

[57]  F. Rösch,et al.  A 44Ti/44Sc radionuclide generator for potential application of 44Sc-based PET-radiopharmaceuticals , 2010 .

[58]  M. Jensen,et al.  119Sb--a potent Auger emitter for targeted radionuclide therapy. , 2008, Medical physics.

[59]  W. Oyen,et al.  Targeted therapy in nuclear medicine--current status and future prospects. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[60]  Markus Jahn,et al.  Processing of Generator-Produced 68Ga for Medical Application , 2007, Journal of Nuclear Medicine.

[61]  F. Rösch,et al.  A 140Nd/140Pr radionuclide generator based on physico-chemical transitions in 140Pr complexes after electron capture decay of 140Nd-DOTA , 2007 .

[62]  G. Anderegg,et al.  CRITICAL EVALUATION OF STABILITY CONSTANTS OF METAL COMPLEXES OF COMPLEXONES FOR BIOMEDICAL AND ENVIRONMENTAL APPLICATIONS , 2005 .

[63]  I. Ostrovskiy,et al.  PAC spectrometer for condensed matter investigation , 2005 .

[64]  Syed M. Qaim,et al.  A no-carrier-added 72Se/72As radionuclide generator based on distillation , 2004 .

[65]  H. Ravn,et al.  The role of diffusion in ISOL targets for the production of radioactive ion beams , 2003 .

[66]  P. Ivanov,et al.  Investigation on the Interaction Between 111 In3+ and DTPA in Water by Electromigration Analysis , 2003 .

[67]  G. Bozhikov,et al.  Study of the 111In-DTPA complex by the electromigration method. , 2003, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[68]  N. Lebedev,et al.  A 111In → 111mCd Radionuclide Generator , 2002 .

[69]  S. Nikitin,et al.  Influence of electron capture after-effects on the stability of 111In(111Cd)-complexes with organic ligands , 2002 .

[70]  D. Soloviev,et al.  Production routes of the alpha emitting 149Tb for medical application , 2002 .

[71]  N. Lebedev,et al.  Production, concentration and deep purification of 111In radiochemicals. , 2001, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[72]  F. Rösch,et al.  A no-carrier-added 72Se/72As isotope generator , 2001 .

[73]  E. Pomplun,et al.  Auger Electron Spectra - The Basic Data for Understanding the Auger Effect , 2000, Acta oncologica.

[74]  Nikolai A. Lebedevb,et al.  Radiochemical separation of no-carrier-added 177 Lu as produced via the 176 Yb n , g 177 Yb 4 177 Lu process , 2000 .

[75]  F. Rösch,et al.  Thermochromatographic separation of no-carrier-added 186Re or 188Re from tungsten targets relevant to nuclear medical applications , 2000 .

[76]  F. Rösch,et al.  Radiochemical separation of no-carrier-added 177Lu as produced via the 176Yb(n,gamma)177Yb-->177Lu process. , 2000, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[77]  D. Schumann,et al.  Sorption Behaviour of W, Hf, Lu, U, and Th on Ion Exchangers from HCI/H2O2 Solutions. Model Experiments for Chemical Studies of Seaborgium (Sg) , 1998 .

[78]  H. Nitsche,et al.  Sorption Behaviour of Uranium on Cation and Anion Exchange Resins from HCl/HF-Containing Aqueous Solutions: Model Experiments for the Determination of Chemical Properties of Element 106 (Seaborgium) , 1997 .

[79]  V. Tsoupko-Sitnikov,et al.  Generator of actinium-225 , 1996 .

[80]  R. Dressler,et al.  Sorption of Subgroup IV, V and VI Elements on Ion Exchangers from HCl/HF Solutions. Model Experiments for Chemical Studies of the Elements 105 and 106 in Aqueous Solution , 1996 .

[81]  Z. Szücs,et al.  Preparation of astatine-labeled monoclonal antibodies , 1995 .

[82]  S. M. Qaim,et al.  Thermochromatographic Separation of 94mTc from Enriched Molybdenum Targets and its Large Scale Production for Nuclear Medical Application , 1994 .

[83]  V. Egorov,et al.  Experimental complex to study nuclei far from the beta-stability line — ISOL-facility YASNAPP-2 , 1992 .

[84]  J. Rehfeld,et al.  The potential of perturbed angular correlation of gamma rays as a tool for dynamic studies of peptides/proteins. , 1991, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[85]  F. Rösch,et al.  Electromigration of Carrier-free Radionuclides 12. Reactions of 239Np(V) with Acetate and Citrate Ligands in Neutral Solutions , 1990 .

[86]  F. Rösch,et al.  Simple Thermochromatographic Separation of 67Ga from Metallic Zinc Targets , 1990 .

[87]  Z. Szücs,et al.  Characterization of DTPA complexes and conjugated antibodies of astatine , 1989 .

[88]  F. Rösch,et al.  Electromigration of carrier-free radionuclides: 13. Ion mobilities and hydrolysis of241Am−Am(III) in aqueous inert electrolytes , 1989 .

[89]  F. Rösch,et al.  Investigation of Astatine Cation Electromigration , 1989 .

[90]  F. Rösch,et al.  Electromigration of Carrier-free Radionuclides 8. Hydrolysis of 249Cf (III) in Aqueous Solution , 1989 .

[91]  F. Rösch,et al.  Electromigration of Carrier-Free Radionuclides. 6. Iodide and Bromide Complexes of Carrier-Free 201Tl(I) in Aqueous Solutions , 1988 .

[92]  F. Rösch,et al.  Electromigration of Carrier-Free Radionuclides. 7. 201Tl-Thallium (I) Sulphate Complexes in Aqueous Solutions , 1988 .

[93]  F. Rösch,et al.  Electromigration of carrier-free radionuclides , 1990 .

[94]  F. Rösch,et al.  Electromigration of carrier-free radionuclide ions Bismuth complexes in aqueous solutions of oxalic, fumaric and succinic acids. , 1987, Talanta.

[95]  F. Rösch,et al.  A simple method for the separation of 111In from silver by thermochromatography , 1986 .

[96]  A. Kovalev,et al.  Fast isobaric separation at the collector of ISOL-facilities , 1981 .

[97]  B. H. Migdalof.  The Use of Thin-Layer Chromatography in Experimental Xenobiology , 1981 .

[98]  N. Lebedev,et al.  Extraction chromatographic separation of carrier-free Tb and Pm generated in (p, xn)-type nuclear reactions , 1976 .

[99]  I. Dudová,et al.  Columns filled with crystalline tellurium for the production of radiochemically pure preparations of astatine , 1972 .

[100]  N. Lebedev,et al.  ISOLATION OF NEUTRON-DEFICIENT ISOTOPES OF ELEMENTS IN THE CERIUM GROUP OF RARE EARTHS FROM ERBIUM IRRADIATED WITH 680 Mev PROTONS , 1964 .

[101]  R. Hain,et al.  Electrophoresis cells modified for determination of labeled protein fractions. , 1956 .

[102]  G. Choppin,et al.  SEPARATION OF THE LANTHANIDES BY ION EXCHANGE WITH ALPHA-HYDROXY ISOBUTYRIC ACID , 1956 .